23S Capital

23S Capital is a private equity and growth capital investment firm based in São Paulo, Brazil, that focuses on scaling high-growth companies across the broader Brazilian economy. The firm operates as a joint venture that deploys capital into sustainable business models operating within sectors such as technology, healthcare, consumer goods, and financial services. The organization launched its operations with approximately $700 million in committed capital to acquire equity stakes in its target markets. The investment vehicle is entirely funded through a strategic partnership between the Brazilian conglomerate Votorantim and the Singapore-based sovereign wealth fund Temasek. The firm maintains a portfolio that includes an initial investment in the consortium administrator Ademicon, alongside board positions in healthcare technology companies Bionexo and MedSênior. 23S Capital was founded in 2022 by Votorantim and Temasek, with Matheus Villares serving as the founding managing partner.